Pharmaceutical Treatment Of BPH And Its Effect On Indications For Prostate Surgery.
Academic Article
Overview
abstract
Benign Prostatic Hyperplasia (BPH) is a pathological description of an aging process that affects a great majority of men. Classically, obstructive and irritative symptoms such as frequency, nocturia and weak urinary stream are described as "prostatism". Microscopically, BPH can be described as hyperplasia of stromal and epithilial cellular element which can macroscopically present as a gross adenomatous enlargement of the prostate gland. Thus, treatment of BPH is aimed at alleviating symptoms of prostatism and associated morbidities of prostatic obstruction.